nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—Cytochrome P450 3A4 Inhibitors—Cyclosporine—systemic lupus erythematosus	0.373	1	CiPCiCtD
Pazopanib—LYN—systemic lupus erythematosus	0.154	0.513	CbGaD
Pazopanib—SH2B3—systemic lupus erythematosus	0.146	0.487	CbGaD
Pazopanib—UGT1A1—Mycophenolate mofetil—systemic lupus erythematosus	0.0161	0.104	CbGbCtD
Pazopanib—ABCG2—Leflunomide—systemic lupus erythematosus	0.0143	0.0923	CbGbCtD
Pazopanib—SLCO1B1—Mycophenolate mofetil—systemic lupus erythematosus	0.0111	0.0718	CbGbCtD
Pazopanib—ABCG2—Mycophenolate mofetil—systemic lupus erythematosus	0.00883	0.057	CbGbCtD
Pazopanib—SLCO1B1—Cyclosporine—systemic lupus erythematosus	0.00843	0.0544	CbGbCtD
Pazopanib—ABCG2—Hydrocortisone—systemic lupus erythematosus	0.00709	0.0458	CbGbCtD
Pazopanib—ABCG2—Cyclosporine—systemic lupus erythematosus	0.00669	0.0432	CbGbCtD
Pazopanib—CYP1A2—Leflunomide—systemic lupus erythematosus	0.0059	0.0381	CbGbCtD
Pazopanib—CYP2C8—Dapsone—systemic lupus erythematosus	0.00543	0.035	CbGbCtD
Pazopanib—CYP2C8—Mycophenolate mofetil—systemic lupus erythematosus	0.0047	0.0304	CbGbCtD
Pazopanib—SLCO1B1—Methotrexate—systemic lupus erythematosus	0.00446	0.0288	CbGbCtD
Pazopanib—ABCG2—Dexamethasone—systemic lupus erythematosus	0.00441	0.0285	CbGbCtD
Pazopanib—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0042	0.0271	CbGbCtD
Pazopanib—CYP2C8—Hydrocortisone—systemic lupus erythematosus	0.00378	0.0244	CbGbCtD
Pazopanib—CYP2C8—Cyclosporine—systemic lupus erythematosus	0.00357	0.023	CbGbCtD
Pazopanib—ABCG2—Methotrexate—systemic lupus erythematosus	0.00354	0.0229	CbGbCtD
Pazopanib—STK10—renal vein—systemic lupus erythematosus	0.00351	0.0741	CbGeAlD
Pazopanib—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.00318	0.0206	CbGbCtD
Pazopanib—ABCB1—Betamethasone—systemic lupus erythematosus	0.00273	0.0176	CbGbCtD
Pazopanib—ABCB1—Prednisolone—systemic lupus erythematosus	0.0027	0.0174	CbGbCtD
Pazopanib—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.00256	0.0165	CbGbCtD
Pazopanib—ABCB1—Prednisone—systemic lupus erythematosus	0.00255	0.0164	CbGbCtD
Pazopanib—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.00252	0.0163	CbGbCtD
Pazopanib—ABCB1—Cyclosporine—systemic lupus erythematosus	0.00241	0.0156	CbGbCtD
Pazopanib—CYP2C8—Dexamethasone—systemic lupus erythematosus	0.00235	0.0152	CbGbCtD
Pazopanib—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.00227	0.0147	CbGbCtD
Pazopanib—CYP3A4—Dapsone—systemic lupus erythematosus	0.0022	0.0142	CbGbCtD
Pazopanib—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00191	0.0123	CbGbCtD
Pazopanib—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00191	0.0123	CbGbCtD
Pazopanib—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00164	0.0106	CbGbCtD
Pazopanib—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00162	0.0104	CbGbCtD
Pazopanib—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00159	0.0103	CbGbCtD
Pazopanib—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00153	0.00989	CbGbCtD
Pazopanib—CYP3A4—Prednisone—systemic lupus erythematosus	0.00153	0.00985	CbGbCtD
Pazopanib—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.0015	0.00967	CbGbCtD
Pazopanib—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00145	0.00934	CbGbCtD
Pazopanib—ABCB1—Methotrexate—systemic lupus erythematosus	0.00128	0.00825	CbGbCtD
Pazopanib—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.000952	0.00615	CbGbCtD
Pazopanib—FLT1—umbilical vein—systemic lupus erythematosus	0.000868	0.0183	CbGeAlD
Pazopanib—TAOK1—blood plasma—systemic lupus erythematosus	0.000764	0.0161	CbGeAlD
Pazopanib—KDR—umbilical vein—systemic lupus erythematosus	0.000734	0.0155	CbGeAlD
Pazopanib—UGT1A1—urine—systemic lupus erythematosus	0.000626	0.0132	CbGeAlD
Pazopanib—LYN—blood plasma—systemic lupus erythematosus	0.000605	0.0128	CbGeAlD
Pazopanib—FLT4—endothelium—systemic lupus erythematosus	0.000529	0.0111	CbGeAlD
Pazopanib—FGF1—endothelium—systemic lupus erythematosus	0.00047	0.0099	CbGeAlD
Pazopanib—MAP3K2—blood plasma—systemic lupus erythematosus	0.000443	0.00933	CbGeAlD
Pazopanib—FGF1—blood plasma—systemic lupus erythematosus	0.000417	0.00879	CbGeAlD
Pazopanib—FLT1—endothelium—systemic lupus erythematosus	0.000411	0.00867	CbGeAlD
Pazopanib—SH2B3—nephron tubule—systemic lupus erythematosus	0.000371	0.00782	CbGeAlD
Pazopanib—FLT1—blood plasma—systemic lupus erythematosus	0.000365	0.0077	CbGeAlD
Pazopanib—KDR—endothelium—systemic lupus erythematosus	0.000348	0.00733	CbGeAlD
Pazopanib—STK10—blood plasma—systemic lupus erythematosus	0.000346	0.00729	CbGeAlD
Pazopanib—TAOK3—blood plasma—systemic lupus erythematosus	0.000344	0.00726	CbGeAlD
Pazopanib—TAOK1—cortex of kidney—systemic lupus erythematosus	0.000337	0.00711	CbGeAlD
Pazopanib—MAP3K9—lung—systemic lupus erythematosus	0.000327	0.00689	CbGeAlD
Pazopanib—ITK—lymphoid tissue—systemic lupus erythematosus	0.000327	0.00689	CbGeAlD
Pazopanib—UGT1A1—blood plasma—systemic lupus erythematosus	0.000327	0.00688	CbGeAlD
Pazopanib—LYN—connective tissue—systemic lupus erythematosus	0.000322	0.00679	CbGeAlD
Pazopanib—FGFR3—connective tissue—systemic lupus erythematosus	0.000321	0.00676	CbGeAlD
Pazopanib—SH2B3—cortex of kidney—systemic lupus erythematosus	0.000318	0.00669	CbGeAlD
Pazopanib—RIOK2—nephron tubule—systemic lupus erythematosus	0.000311	0.00654	CbGeAlD
Pazopanib—KDR—blood plasma—systemic lupus erythematosus	0.000309	0.00651	CbGeAlD
Pazopanib—KIT—endothelium—systemic lupus erythematosus	0.000308	0.00649	CbGeAlD
Pazopanib—MAP3K9—nervous system—systemic lupus erythematosus	0.000303	0.00638	CbGeAlD
Pazopanib—CSF1R—blood plasma—systemic lupus erythematosus	0.000301	0.00635	CbGeAlD
Pazopanib—ITK—bone marrow—systemic lupus erythematosus	0.000298	0.00627	CbGeAlD
Pazopanib—MAP3K9—central nervous system—systemic lupus erythematosus	0.000291	0.00614	CbGeAlD
Pazopanib—FGFR3—skin of body—systemic lupus erythematosus	0.000289	0.0061	CbGeAlD
Pazopanib—SH2B3—lymphoid tissue—systemic lupus erythematosus	0.00028	0.0059	CbGeAlD
Pazopanib—CYP1A2—urine—systemic lupus erythematosus	0.000277	0.00584	CbGeAlD
Pazopanib—PI4KB—nephron tubule—systemic lupus erythematosus	0.000275	0.00579	CbGeAlD
Pazopanib—KIT—blood plasma—systemic lupus erythematosus	0.000274	0.00577	CbGeAlD
Pazopanib—FGFR3—kidney—systemic lupus erythematosus	0.000273	0.00575	CbGeAlD
Pazopanib—SLCO1B1—blood plasma—systemic lupus erythematosus	0.000272	0.00573	CbGeAlD
Pazopanib—TAOK1—bone marrow—systemic lupus erythematosus	0.000271	0.00571	CbGeAlD
Pazopanib—ITK—lung—systemic lupus erythematosus	0.00027	0.00568	CbGeAlD
Pazopanib—RIOK2—cortex of kidney—systemic lupus erythematosus	0.000266	0.0056	CbGeAlD
Pazopanib—FGFR3—cortex of kidney—systemic lupus erythematosus	0.000266	0.0056	CbGeAlD
Pazopanib—SH2B3—tendon—systemic lupus erythematosus	0.000263	0.00555	CbGeAlD
Pazopanib—AURKC—tendon—systemic lupus erythematosus	0.000259	0.00546	CbGeAlD
Pazopanib—SH2B3—bone marrow—systemic lupus erythematosus	0.000255	0.00537	CbGeAlD
Pazopanib—PLK4—lymphoid tissue—systemic lupus erythematosus	0.000252	0.00531	CbGeAlD
Pazopanib—TAOK1—lung—systemic lupus erythematosus	0.000245	0.00517	CbGeAlD
Pazopanib—PI4KB—kidney—systemic lupus erythematosus	0.000241	0.00509	CbGeAlD
Pazopanib—PIP4K2C—nephron tubule—systemic lupus erythematosus	0.000241	0.00508	CbGeAlD
Pazopanib—STK36—cortex of kidney—systemic lupus erythematosus	0.000239	0.00503	CbGeAlD
Pazopanib—STK16—lymphoid tissue—systemic lupus erythematosus	0.000238	0.00502	CbGeAlD
Pazopanib—MAP3K2—connective tissue—systemic lupus erythematosus	0.000236	0.00497	CbGeAlD
Pazopanib—LYN—lymphoid tissue—systemic lupus erythematosus	0.000236	0.00496	CbGeAlD
Pazopanib—PI4KB—cortex of kidney—systemic lupus erythematosus	0.000235	0.00495	CbGeAlD
Pazopanib—SH2B3—lung—systemic lupus erythematosus	0.000231	0.00487	CbGeAlD
Pazopanib—LIMK2—cortex of kidney—systemic lupus erythematosus	0.000231	0.00486	CbGeAlD
Pazopanib—PLK4—bone marrow—systemic lupus erythematosus	0.00023	0.00484	CbGeAlD
Pazopanib—MAP3K2—nephron tubule—systemic lupus erythematosus	0.000228	0.00481	CbGeAlD
Pazopanib—TAOK1—nervous system—systemic lupus erythematosus	0.000227	0.00479	CbGeAlD
Pazopanib—STK16—tendon—systemic lupus erythematosus	0.000224	0.00472	CbGeAlD
Pazopanib—FGF1—connective tissue—systemic lupus erythematosus	0.000222	0.00468	CbGeAlD
Pazopanib—RIOK2—tendon—systemic lupus erythematosus	0.00022	0.00464	CbGeAlD
Pazopanib—TAOK1—central nervous system—systemic lupus erythematosus	0.000219	0.00461	CbGeAlD
Pazopanib—FGF1—nephron tubule—systemic lupus erythematosus	0.000215	0.00454	CbGeAlD
Pazopanib—SH2B3—nervous system—systemic lupus erythematosus	0.000214	0.00451	CbGeAlD
Pazopanib—RIOK2—bone marrow—systemic lupus erythematosus	0.000213	0.0045	CbGeAlD
Pazopanib—AURKC—nervous system—systemic lupus erythematosus	0.000211	0.00444	CbGeAlD
Pazopanib—FGFR2—connective tissue—systemic lupus erythematosus	0.00021	0.00442	CbGeAlD
Pazopanib—PLK4—lung—systemic lupus erythematosus	0.000208	0.00438	CbGeAlD
Pazopanib—FLT4—cortex of kidney—systemic lupus erythematosus	0.000207	0.00437	CbGeAlD
Pazopanib—PIP4K2C—cortex of kidney—systemic lupus erythematosus	0.000206	0.00435	CbGeAlD
Pazopanib—SH2B3—central nervous system—systemic lupus erythematosus	0.000206	0.00434	CbGeAlD
Pazopanib—FGFR1—cortex of kidney—systemic lupus erythematosus	0.000205	0.00431	CbGeAlD
Pazopanib—LIMK2—lymphoid tissue—systemic lupus erythematosus	0.000204	0.00429	CbGeAlD
Pazopanib—AURKC—central nervous system—systemic lupus erythematosus	0.000203	0.00427	CbGeAlD
Pazopanib—FGF1—skin of body—systemic lupus erythematosus	0.000201	0.00423	CbGeAlD
Pazopanib—CYP3A4—urine—systemic lupus erythematosus	0.000201	0.00423	CbGeAlD
Pazopanib—STK36—tendon—systemic lupus erythematosus	0.000198	0.00417	CbGeAlD
Pazopanib—CYP2D6—urine—systemic lupus erythematosus	0.000197	0.00416	CbGeAlD
Pazopanib—STK16—lung—systemic lupus erythematosus	0.000196	0.00414	CbGeAlD
Pazopanib—PI4KB—tendon—systemic lupus erythematosus	0.000195	0.00411	CbGeAlD
Pazopanib—FLT1—connective tissue—systemic lupus erythematosus	0.000195	0.0041	CbGeAlD
Pazopanib—FGFR3—lung—systemic lupus erythematosus	0.000193	0.00407	CbGeAlD
Pazopanib—RIOK2—lung—systemic lupus erythematosus	0.000193	0.00407	CbGeAlD
Pazopanib—MAP3K19—lung—systemic lupus erythematosus	0.000191	0.00403	CbGeAlD
Pazopanib—BMPR1B—lung—systemic lupus erythematosus	0.000191	0.00403	CbGeAlD
Pazopanib—FGFR2—skin of body—systemic lupus erythematosus	0.000189	0.00399	CbGeAlD
Pazopanib—FGF1—kidney—systemic lupus erythematosus	0.000189	0.00399	CbGeAlD
Pazopanib—PI4KB—bone marrow—systemic lupus erythematosus	0.000189	0.00398	CbGeAlD
Pazopanib—FLT1—nephron tubule—systemic lupus erythematosus	0.000188	0.00397	CbGeAlD
Pazopanib—FGF1—cortex of kidney—systemic lupus erythematosus	0.000184	0.00388	CbGeAlD
Pazopanib—TAOK3—connective tissue—systemic lupus erythematosus	0.000183	0.00386	CbGeAlD
Pazopanib—FLT4—lymphoid tissue—systemic lupus erythematosus	0.000183	0.00385	CbGeAlD
Pazopanib—PDGFRA—connective tissue—systemic lupus erythematosus	0.000182	0.00384	CbGeAlD
Pazopanib—STK16—nervous system—systemic lupus erythematosus	0.000182	0.00383	CbGeAlD
Pazopanib—LYN—nervous system—systemic lupus erythematosus	0.00018	0.00379	CbGeAlD
Pazopanib—FGFR3—nervous system—systemic lupus erythematosus	0.000179	0.00377	CbGeAlD
Pazopanib—RIOK2—nervous system—systemic lupus erythematosus	0.000179	0.00377	CbGeAlD
Pazopanib—FGFR2—kidney—systemic lupus erythematosus	0.000179	0.00376	CbGeAlD
Pazopanib—TAOK3—nephron tubule—systemic lupus erythematosus	0.000178	0.00374	CbGeAlD
Pazopanib—MAP3K19—nervous system—systemic lupus erythematosus	0.000177	0.00374	CbGeAlD
Pazopanib—BMPR1B—nervous system—systemic lupus erythematosus	0.000177	0.00374	CbGeAlD
Pazopanib—STK16—central nervous system—systemic lupus erythematosus	0.000175	0.00369	CbGeAlD
Pazopanib—STK36—lung—systemic lupus erythematosus	0.000174	0.00366	CbGeAlD
Pazopanib—EPHB6—skin of body—systemic lupus erythematosus	0.000174	0.00366	CbGeAlD
Pazopanib—LYN—central nervous system—systemic lupus erythematosus	0.000173	0.00365	CbGeAlD
Pazopanib—MAP3K2—lymphoid tissue—systemic lupus erythematosus	0.000172	0.00363	CbGeAlD
Pazopanib—RIOK2—central nervous system—systemic lupus erythematosus	0.000172	0.00363	CbGeAlD
Pazopanib—FGFR3—central nervous system—systemic lupus erythematosus	0.000172	0.00363	CbGeAlD
Pazopanib—PI4KB—lung—systemic lupus erythematosus	0.000171	0.0036	CbGeAlD
Pazopanib—PIP4K2C—tendon—systemic lupus erythematosus	0.000171	0.0036	CbGeAlD
Pazopanib—MAP3K19—central nervous system—systemic lupus erythematosus	0.000171	0.0036	CbGeAlD
Pazopanib—BMPR1B—central nervous system—systemic lupus erythematosus	0.000171	0.0036	CbGeAlD
Pazopanib—FGFR1—tendon—systemic lupus erythematosus	0.00017	0.00357	CbGeAlD
Pazopanib—LIMK2—lung—systemic lupus erythematosus	0.000168	0.00354	CbGeAlD
Pazopanib—FLT4—bone marrow—systemic lupus erythematosus	0.000167	0.00351	CbGeAlD
Pazopanib—PIP4K2C—bone marrow—systemic lupus erythematosus	0.000166	0.00349	CbGeAlD
Pazopanib—FLT1—kidney—systemic lupus erythematosus	0.000166	0.00349	CbGeAlD
Pazopanib—KDR—connective tissue—systemic lupus erythematosus	0.000164	0.00346	CbGeAlD
Pazopanib—FGF1—lymphoid tissue—systemic lupus erythematosus	0.000162	0.00342	CbGeAlD
Pazopanib—FLT1—cortex of kidney—systemic lupus erythematosus	0.000161	0.0034	CbGeAlD
Pazopanib—STK36—nervous system—systemic lupus erythematosus	0.000161	0.00339	CbGeAlD
Pazopanib—CSF1R—connective tissue—systemic lupus erythematosus	0.00016	0.00338	CbGeAlD
Pazopanib—EPHB6—cortex of kidney—systemic lupus erythematosus	0.000159	0.00336	CbGeAlD
Pazopanib—KDR—nephron tubule—systemic lupus erythematosus	0.000159	0.00336	CbGeAlD
Pazopanib—PI4KB—nervous system—systemic lupus erythematosus	0.000158	0.00334	CbGeAlD
Pazopanib—MAP3K2—bone marrow—systemic lupus erythematosus	0.000157	0.00331	CbGeAlD
Pazopanib—STK10—kidney—systemic lupus erythematosus	0.000157	0.0033	CbGeAlD
Pazopanib—TAOK3—kidney—systemic lupus erythematosus	0.000156	0.00329	CbGeAlD
Pazopanib—LIMK2—nervous system—systemic lupus erythematosus	0.000155	0.00328	CbGeAlD
Pazopanib—STK36—central nervous system—systemic lupus erythematosus	0.000155	0.00326	CbGeAlD
Pazopanib—CYP2C8—blood plasma—systemic lupus erythematosus	0.000155	0.00326	CbGeAlD
Pazopanib—PI4KB—central nervous system—systemic lupus erythematosus	0.000152	0.00321	CbGeAlD
Pazopanib—TAOK3—cortex of kidney—systemic lupus erythematosus	0.000152	0.0032	CbGeAlD
Pazopanib—FLT4—lung—systemic lupus erythematosus	0.000151	0.00318	CbGeAlD
Pazopanib—PIP4K2C—lung—systemic lupus erythematosus	0.00015	0.00316	CbGeAlD
Pazopanib—LIMK2—central nervous system—systemic lupus erythematosus	0.00015	0.00315	CbGeAlD
Pazopanib—FGFR1—lung—systemic lupus erythematosus	0.000149	0.00314	CbGeAlD
Pazopanib—UGT1A1—kidney—systemic lupus erythematosus	0.000148	0.00312	CbGeAlD
Pazopanib—LCK—bone marrow—systemic lupus erythematosus	0.000147	0.0031	CbGeAlD
Pazopanib—KIT—connective tissue—systemic lupus erythematosus	0.000146	0.00307	CbGeAlD
Pazopanib—CSF1R—skin of body—systemic lupus erythematosus	0.000145	0.00305	CbGeAlD
Pazopanib—CYP1A2—blood plasma—systemic lupus erythematosus	0.000145	0.00305	CbGeAlD
Pazopanib—PDGFRB—connective tissue—systemic lupus erythematosus	0.000142	0.003	CbGeAlD
Pazopanib—MAP3K2—lung—systemic lupus erythematosus	0.000142	0.003	CbGeAlD
Pazopanib—FLT1—lymphoid tissue—systemic lupus erythematosus	0.000142	0.003	CbGeAlD
Pazopanib—KIT—nephron tubule—systemic lupus erythematosus	0.000141	0.00297	CbGeAlD
Pazopanib—KDR—kidney—systemic lupus erythematosus	0.00014	0.00295	CbGeAlD
Pazopanib—PIP4K2C—nervous system—systemic lupus erythematosus	0.000139	0.00293	CbGeAlD
Pazopanib—MAP2K5—cortex of kidney—systemic lupus erythematosus	0.000136	0.00287	CbGeAlD
Pazopanib—KDR—cortex of kidney—systemic lupus erythematosus	0.000136	0.00287	CbGeAlD
Pazopanib—STK10—lymphoid tissue—systemic lupus erythematosus	0.000135	0.00284	CbGeAlD
Pazopanib—TAOK3—lymphoid tissue—systemic lupus erythematosus	0.000134	0.00283	CbGeAlD
Pazopanib—FGF1—lung—systemic lupus erythematosus	0.000134	0.00282	CbGeAlD
Pazopanib—PIP4K2C—central nervous system—systemic lupus erythematosus	0.000134	0.00282	CbGeAlD
Pazopanib—FLT1—tendon—systemic lupus erythematosus	0.000134	0.00282	CbGeAlD
Pazopanib—PDGFRA—lymphoid tissue—systemic lupus erythematosus	0.000133	0.00281	CbGeAlD
Pazopanib—LCK—lung—systemic lupus erythematosus	0.000133	0.00281	CbGeAlD
Pazopanib—EPHB6—tendon—systemic lupus erythematosus	0.000132	0.00278	CbGeAlD
Pazopanib—MAP3K2—nervous system—systemic lupus erythematosus	0.000132	0.00278	CbGeAlD
Pazopanib—KIT—skin of body—systemic lupus erythematosus	0.000132	0.00277	CbGeAlD
Pazopanib—PDGFRB—skin of body—systemic lupus erythematosus	0.000129	0.00271	CbGeAlD
Pazopanib—MAP3K2—central nervous system—systemic lupus erythematosus	0.000127	0.00267	CbGeAlD
Pazopanib—FGFR2—lung—systemic lupus erythematosus	0.000127	0.00267	CbGeAlD
Pazopanib—STK10—tendon—systemic lupus erythematosus	0.000127	0.00267	CbGeAlD
Pazopanib—TAOK3—tendon—systemic lupus erythematosus	0.000126	0.00266	CbGeAlD
Pazopanib—PDGFRA—tendon—systemic lupus erythematosus	0.000125	0.00264	CbGeAlD
Pazopanib—FGF1—nervous system—systemic lupus erythematosus	0.000124	0.00262	CbGeAlD
Pazopanib—KIT—kidney—systemic lupus erythematosus	0.000124	0.00261	CbGeAlD
Pazopanib—SLCO1B1—kidney—systemic lupus erythematosus	0.000123	0.0026	CbGeAlD
Pazopanib—STK10—bone marrow—systemic lupus erythematosus	0.000123	0.00258	CbGeAlD
Pazopanib—TAOK3—bone marrow—systemic lupus erythematosus	0.000122	0.00257	CbGeAlD
Pazopanib—PDGFRB—kidney—systemic lupus erythematosus	0.000121	0.00255	CbGeAlD
Pazopanib—KIT—cortex of kidney—systemic lupus erythematosus	0.000121	0.00255	CbGeAlD
Pazopanib—KDR—lymphoid tissue—systemic lupus erythematosus	0.00012	0.00253	CbGeAlD
Pazopanib—FGF1—central nervous system—systemic lupus erythematosus	0.000119	0.00252	CbGeAlD
Pazopanib—PDGFRB—cortex of kidney—systemic lupus erythematosus	0.000118	0.00249	CbGeAlD
Pazopanib—CSF1R—lymphoid tissue—systemic lupus erythematosus	0.000117	0.00247	CbGeAlD
Pazopanib—FLT1—lung—systemic lupus erythematosus	0.000117	0.00247	CbGeAlD
Pazopanib—FGFR2—nervous system—systemic lupus erythematosus	0.000117	0.00247	CbGeAlD
Pazopanib—EPHB6—lung—systemic lupus erythematosus	0.000116	0.00244	CbGeAlD
Pazopanib—KDR—tendon—systemic lupus erythematosus	0.000113	0.00238	CbGeAlD
Pazopanib—MAP2K5—tendon—systemic lupus erythematosus	0.000113	0.00238	CbGeAlD
Pazopanib—FGFR2—central nervous system—systemic lupus erythematosus	0.000113	0.00238	CbGeAlD
Pazopanib—STK10—lung—systemic lupus erythematosus	0.000111	0.00234	CbGeAlD
Pazopanib—TAOK3—lung—systemic lupus erythematosus	0.000111	0.00233	CbGeAlD
Pazopanib—CSF1R—tendon—systemic lupus erythematosus	0.00011	0.00232	CbGeAlD
Pazopanib—PDGFRA—lung—systemic lupus erythematosus	0.00011	0.00232	CbGeAlD
Pazopanib—KDR—bone marrow—systemic lupus erythematosus	0.000109	0.00231	CbGeAlD
Pazopanib—SH2B3—Betamethasone—Hydrocortisone—systemic lupus erythematosus	0.000109	0.0912	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Hydrocortisone—systemic lupus erythematosus	0.000109	0.0912	CbGdCrCtD
Pazopanib—FLT1—nervous system—systemic lupus erythematosus	0.000109	0.00229	CbGeAlD
Pazopanib—EPHB6—nervous system—systemic lupus erythematosus	0.000107	0.00226	CbGeAlD
Pazopanib—CSF1R—bone marrow—systemic lupus erythematosus	0.000107	0.00225	CbGeAlD
Pazopanib—KIT—lymphoid tissue—systemic lupus erythematosus	0.000107	0.00225	CbGeAlD
Pazopanib—CYP3A4—blood plasma—systemic lupus erythematosus	0.000105	0.00221	CbGeAlD
Pazopanib—FLT1—central nervous system—systemic lupus erythematosus	0.000105	0.0022	CbGeAlD
Pazopanib—PDGFRB—lymphoid tissue—systemic lupus erythematosus	0.000104	0.00219	CbGeAlD
Pazopanib—EPHB6—central nervous system—systemic lupus erythematosus	0.000103	0.00218	CbGeAlD
Pazopanib—CYP2D6—blood plasma—systemic lupus erythematosus	0.000103	0.00217	CbGeAlD
Pazopanib—SH2B3—Betamethasone—Methylprednisolone—systemic lupus erythematosus	0.000103	0.0861	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Methylprednisolone—systemic lupus erythematosus	0.000103	0.0861	CbGdCrCtD
Pazopanib—STK10—nervous system—systemic lupus erythematosus	0.000103	0.00217	CbGeAlD
Pazopanib—TAOK3—nervous system—systemic lupus erythematosus	0.000102	0.00216	CbGeAlD
Pazopanib—PDGFRA—nervous system—systemic lupus erythematosus	0.000102	0.00215	CbGeAlD
Pazopanib—SH2B3—Dexamethasone—Betamethasone—systemic lupus erythematosus	0.000101	0.0847	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Dexamethasone—systemic lupus erythematosus	0.000101	0.0847	CbGdCrCtD
Pazopanib—MAP2K5—lung—systemic lupus erythematosus	9.92e-05	0.00209	CbGeAlD
Pazopanib—KDR—lung—systemic lupus erythematosus	9.92e-05	0.00209	CbGeAlD
Pazopanib—STK10—central nervous system—systemic lupus erythematosus	9.9e-05	0.00209	CbGeAlD
Pazopanib—SH2B3—Dexamethasone—Triamcinolone—systemic lupus erythematosus	9.9e-05	0.0828	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Triamcinolone—systemic lupus erythematosus	9.9e-05	0.0828	CbGdCrCtD
Pazopanib—TAOK3—central nervous system—systemic lupus erythematosus	9.86e-05	0.00208	CbGeAlD
Pazopanib—PDGFRA—central nervous system—systemic lupus erythematosus	9.8e-05	0.00207	CbGeAlD
Pazopanib—PDGFRB—tendon—systemic lupus erythematosus	9.78e-05	0.00206	CbGeAlD
Pazopanib—KIT—bone marrow—systemic lupus erythematosus	9.7e-05	0.00204	CbGeAlD
Pazopanib—CSF1R—lung—systemic lupus erythematosus	9.68e-05	0.00204	CbGeAlD
Pazopanib—PDGFRB—bone marrow—systemic lupus erythematosus	9.48e-05	0.002	CbGeAlD
Pazopanib—SH2B3—Betamethasone—Prednisone—systemic lupus erythematosus	9.39e-05	0.0785	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Prednisone—systemic lupus erythematosus	9.39e-05	0.0785	CbGdCrCtD
Pazopanib—KDR—nervous system—systemic lupus erythematosus	9.18e-05	0.00194	CbGeAlD
Pazopanib—MAP2K5—nervous system—systemic lupus erythematosus	9.18e-05	0.00194	CbGeAlD
Pazopanib—SH2B3—Betamethasone—Prednisolone—systemic lupus erythematosus	9.17e-05	0.0767	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Prednisolone—systemic lupus erythematosus	9.17e-05	0.0767	CbGdCrCtD
Pazopanib—CSF1R—nervous system—systemic lupus erythematosus	8.96e-05	0.00189	CbGeAlD
Pazopanib—KDR—central nervous system—systemic lupus erythematosus	8.84e-05	0.00186	CbGeAlD
Pazopanib—MAP2K5—central nervous system—systemic lupus erythematosus	8.84e-05	0.00186	CbGeAlD
Pazopanib—KIT—lung—systemic lupus erythematosus	8.79e-05	0.00185	CbGeAlD
Pazopanib—CSF1R—central nervous system—systemic lupus erythematosus	8.63e-05	0.00182	CbGeAlD
Pazopanib—PDGFRB—lung—systemic lupus erythematosus	8.58e-05	0.00181	CbGeAlD
Pazopanib—KIT—nervous system—systemic lupus erythematosus	8.14e-05	0.00172	CbGeAlD
Pazopanib—PDGFRB—nervous system—systemic lupus erythematosus	7.95e-05	0.00168	CbGeAlD
Pazopanib—KIT—central nervous system—systemic lupus erythematosus	7.84e-05	0.00165	CbGeAlD
Pazopanib—ABCG2—nephron tubule—systemic lupus erythematosus	7.75e-05	0.00163	CbGeAlD
Pazopanib—PDGFRB—central nervous system—systemic lupus erythematosus	7.65e-05	0.00161	CbGeAlD
Pazopanib—ABCB1—blood plasma—systemic lupus erythematosus	7.41e-05	0.00156	CbGeAlD
Pazopanib—CYP2C8—kidney—systemic lupus erythematosus	7e-05	0.00148	CbGeAlD
Pazopanib—ABCG2—bone marrow—systemic lupus erythematosus	5.33e-05	0.00112	CbGeAlD
Pazopanib—ABCG2—lung—systemic lupus erythematosus	4.82e-05	0.00102	CbGeAlD
Pazopanib—CYP3A4—kidney—systemic lupus erythematosus	4.74e-05	0.001	CbGeAlD
Pazopanib—CYP2D6—kidney—systemic lupus erythematosus	4.67e-05	0.000984	CbGeAlD
Pazopanib—CYP1A2—lung—systemic lupus erythematosus	4.64e-05	0.000979	CbGeAlD
Pazopanib—ABCB1—nephron tubule—systemic lupus erythematosus	3.82e-05	0.000805	CbGeAlD
Pazopanib—ABCB1—kidney—systemic lupus erythematosus	3.36e-05	0.000708	CbGeAlD
Pazopanib—Dry mouth—Triamcinolone—systemic lupus erythematosus	3.34e-05	0.000586	CcSEcCtD
Pazopanib—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	3.31e-05	0.000582	CcSEcCtD
Pazopanib—Anorexia—Hydrocortisone—systemic lupus erythematosus	3.31e-05	0.000582	CcSEcCtD
Pazopanib—Stomatitis—Methotrexate—systemic lupus erythematosus	3.3e-05	0.00058	CcSEcCtD
Pazopanib—Angiopathy—Prednisone—systemic lupus erythematosus	3.3e-05	0.00058	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	3.29e-05	0.000578	CcSEcCtD
Pazopanib—Oedema—Triamcinolone—systemic lupus erythematosus	3.27e-05	0.000575	CcSEcCtD
Pazopanib—ABCB1—cortex of kidney—systemic lupus erythematosus	3.27e-05	0.000689	CbGeAlD
Pazopanib—Syncope—Betamethasone—systemic lupus erythematosus	3.26e-05	0.000573	CcSEcCtD
Pazopanib—Syncope—Dexamethasone—systemic lupus erythematosus	3.26e-05	0.000573	CcSEcCtD
Pazopanib—Pain—Mycophenolate mofetil—systemic lupus erythematosus	3.26e-05	0.000573	CcSEcCtD
Pazopanib—Infection—Triamcinolone—systemic lupus erythematosus	3.25e-05	0.000571	CcSEcCtD
Pazopanib—Infection—Methylprednisolone—systemic lupus erythematosus	3.24e-05	0.00057	CcSEcCtD
Pazopanib—Haematuria—Methotrexate—systemic lupus erythematosus	3.23e-05	0.000567	CcSEcCtD
Pazopanib—Vomiting—Leflunomide—systemic lupus erythematosus	3.22e-05	0.000566	CcSEcCtD
Pazopanib—Shock—Triamcinolone—systemic lupus erythematosus	3.22e-05	0.000565	CcSEcCtD
Pazopanib—Insomnia—Prednisolone—systemic lupus erythematosus	3.22e-05	0.000565	CcSEcCtD
Pazopanib—Alopecia—Prednisone—systemic lupus erythematosus	3.21e-05	0.000565	CcSEcCtD
Pazopanib—Shock—Methylprednisolone—systemic lupus erythematosus	3.21e-05	0.000564	CcSEcCtD
Pazopanib—Hepatobiliary disease—Methotrexate—systemic lupus erythematosus	3.2e-05	0.000563	CcSEcCtD
Pazopanib—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	3.2e-05	0.000562	CcSEcCtD
Pazopanib—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	3.2e-05	0.000562	CcSEcCtD
Pazopanib—Loss of consciousness—Betamethasone—systemic lupus erythematosus	3.2e-05	0.000562	CcSEcCtD
Pazopanib—Loss of consciousness—Dexamethasone—systemic lupus erythematosus	3.2e-05	0.000562	CcSEcCtD
Pazopanib—Epistaxis—Methotrexate—systemic lupus erythematosus	3.19e-05	0.000561	CcSEcCtD
Pazopanib—Paraesthesia—Prednisolone—systemic lupus erythematosus	3.19e-05	0.000561	CcSEcCtD
Pazopanib—Rash—Leflunomide—systemic lupus erythematosus	3.19e-05	0.000561	CcSEcCtD
Pazopanib—Dermatitis—Leflunomide—systemic lupus erythematosus	3.19e-05	0.000561	CcSEcCtD
Pazopanib—Mental disorder—Prednisone—systemic lupus erythematosus	3.19e-05	0.00056	CcSEcCtD
Pazopanib—Nausea—Azathioprine—systemic lupus erythematosus	3.19e-05	0.00056	CcSEcCtD
Pazopanib—Headache—Leflunomide—systemic lupus erythematosus	3.17e-05	0.000558	CcSEcCtD
Pazopanib—Skin disorder—Methylprednisolone—systemic lupus erythematosus	3.17e-05	0.000557	CcSEcCtD
Pazopanib—Erythema—Prednisone—systemic lupus erythematosus	3.17e-05	0.000556	CcSEcCtD
Pazopanib—Malnutrition—Prednisone—systemic lupus erythematosus	3.17e-05	0.000556	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	3.16e-05	0.000556	CcSEcCtD
Pazopanib—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	3.16e-05	0.000556	CcSEcCtD
Pazopanib—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	3.15e-05	0.000554	CcSEcCtD
Pazopanib—Insomnia—Hydrocortisone—systemic lupus erythematosus	3.14e-05	0.000552	CcSEcCtD
Pazopanib—Hypertension—Betamethasone—systemic lupus erythematosus	3.14e-05	0.000552	CcSEcCtD
Pazopanib—Hypertension—Dexamethasone—systemic lupus erythematosus	3.14e-05	0.000552	CcSEcCtD
Pazopanib—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	3.12e-05	0.000548	CcSEcCtD
Pazopanib—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	3.12e-05	0.000548	CcSEcCtD
Pazopanib—CYP3A4—nervous system—systemic lupus erythematosus	3.11e-05	0.000656	CbGeAlD
Pazopanib—Myalgia—Dexamethasone—systemic lupus erythematosus	3.1e-05	0.000544	CcSEcCtD
Pazopanib—Myalgia—Betamethasone—systemic lupus erythematosus	3.1e-05	0.000544	CcSEcCtD
Pazopanib—Abdominal pain—Cyclosporine—systemic lupus erythematosus	3.09e-05	0.000543	CcSEcCtD
Pazopanib—CYP2D6—nervous system—systemic lupus erythematosus	3.06e-05	0.000645	CbGeAlD
Pazopanib—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	3.06e-05	0.000537	CcSEcCtD
Pazopanib—Haemoglobin—Methotrexate—systemic lupus erythematosus	3.06e-05	0.000537	CcSEcCtD
Pazopanib—Pain—Prednisolone—systemic lupus erythematosus	3.04e-05	0.000534	CcSEcCtD
Pazopanib—Haemorrhage—Methotrexate—systemic lupus erythematosus	3.04e-05	0.000534	CcSEcCtD
Pazopanib—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	3.02e-05	0.000531	CcSEcCtD
Pazopanib—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	3.01e-05	0.00053	CcSEcCtD
Pazopanib—Nausea—Leflunomide—systemic lupus erythematosus	3.01e-05	0.000529	CcSEcCtD
Pazopanib—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	3e-05	0.000528	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	3e-05	0.000527	CcSEcCtD
Pazopanib—CYP3A4—central nervous system—systemic lupus erythematosus	3e-05	0.000631	CbGeAlD
Pazopanib—Fatigue—Hydrocortisone—systemic lupus erythematosus	2.99e-05	0.000526	CcSEcCtD
Pazopanib—Vision blurred—Prednisone—systemic lupus erythematosus	2.98e-05	0.000524	CcSEcCtD
Pazopanib—Urethral disorder—Methotrexate—systemic lupus erythematosus	2.98e-05	0.000524	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	2.98e-05	0.000524	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	2.97e-05	0.000523	CcSEcCtD
Pazopanib—Pain—Hydrocortisone—systemic lupus erythematosus	2.97e-05	0.000522	CcSEcCtD
Pazopanib—Oedema—Betamethasone—systemic lupus erythematosus	2.97e-05	0.000522	CcSEcCtD
Pazopanib—Oedema—Dexamethasone—systemic lupus erythematosus	2.97e-05	0.000522	CcSEcCtD
Pazopanib—Insomnia—Triamcinolone—systemic lupus erythematosus	2.96e-05	0.00052	CcSEcCtD
Pazopanib—Insomnia—Methylprednisolone—systemic lupus erythematosus	2.95e-05	0.000519	CcSEcCtD
Pazopanib—CYP2D6—central nervous system—systemic lupus erythematosus	2.95e-05	0.000621	CbGeAlD
Pazopanib—Infection—Betamethasone—systemic lupus erythematosus	2.95e-05	0.000518	CcSEcCtD
Pazopanib—Infection—Dexamethasone—systemic lupus erythematosus	2.95e-05	0.000518	CcSEcCtD
Pazopanib—Paraesthesia—Triamcinolone—systemic lupus erythematosus	2.94e-05	0.000516	CcSEcCtD
Pazopanib—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	2.93e-05	0.000515	CcSEcCtD
Pazopanib—Anaemia—Prednisone—systemic lupus erythematosus	2.93e-05	0.000514	CcSEcCtD
Pazopanib—Shock—Dexamethasone—systemic lupus erythematosus	2.92e-05	0.000513	CcSEcCtD
Pazopanib—Shock—Betamethasone—systemic lupus erythematosus	2.92e-05	0.000513	CcSEcCtD
Pazopanib—Dyspnoea—Triamcinolone—systemic lupus erythematosus	2.92e-05	0.000512	CcSEcCtD
Pazopanib—Nervous system disorder—Betamethasone—systemic lupus erythematosus	2.91e-05	0.000511	CcSEcCtD
Pazopanib—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	2.91e-05	0.000511	CcSEcCtD
Pazopanib—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	2.91e-05	0.000511	CcSEcCtD
Pazopanib—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	2.91e-05	0.000511	CcSEcCtD
Pazopanib—ABCB1—lymphoid tissue—systemic lupus erythematosus	2.88e-05	0.000608	CbGeAlD
Pazopanib—Dyspepsia—Triamcinolone—systemic lupus erythematosus	2.88e-05	0.000506	CcSEcCtD
Pazopanib—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	2.87e-05	0.000505	CcSEcCtD
Pazopanib—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	2.87e-05	0.000504	CcSEcCtD
Pazopanib—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	2.87e-05	0.000504	CcSEcCtD
Pazopanib—Eye disorder—Methotrexate—systemic lupus erythematosus	2.84e-05	0.000499	CcSEcCtD
Pazopanib—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	2.84e-05	0.000499	CcSEcCtD
Pazopanib—Syncope—Prednisone—systemic lupus erythematosus	2.84e-05	0.000499	CcSEcCtD
Pazopanib—Anorexia—Betamethasone—systemic lupus erythematosus	2.83e-05	0.000497	CcSEcCtD
Pazopanib—Anorexia—Dexamethasone—systemic lupus erythematosus	2.83e-05	0.000497	CcSEcCtD
Pazopanib—Cardiac disorder—Methotrexate—systemic lupus erythematosus	2.82e-05	0.000496	CcSEcCtD
Pazopanib—Fatigue—Triamcinolone—systemic lupus erythematosus	2.82e-05	0.000496	CcSEcCtD
Pazopanib—Fatigue—Methylprednisolone—systemic lupus erythematosus	2.81e-05	0.000494	CcSEcCtD
Pazopanib—Asthenia—Cyclosporine—systemic lupus erythematosus	2.8e-05	0.000493	CcSEcCtD
Pazopanib—Pain—Triamcinolone—systemic lupus erythematosus	2.8e-05	0.000492	CcSEcCtD
Pazopanib—Loss of consciousness—Prednisone—systemic lupus erythematosus	2.78e-05	0.000489	CcSEcCtD
Pazopanib—Pruritus—Cyclosporine—systemic lupus erythematosus	2.77e-05	0.000486	CcSEcCtD
Pazopanib—Angiopathy—Methotrexate—systemic lupus erythematosus	2.76e-05	0.000485	CcSEcCtD
Pazopanib—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	2.75e-05	0.000483	CcSEcCtD
Pazopanib—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	2.74e-05	0.000482	CcSEcCtD
Pazopanib—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	2.74e-05	0.000481	CcSEcCtD
Pazopanib—Hypertension—Prednisone—systemic lupus erythematosus	2.73e-05	0.00048	CcSEcCtD
Pazopanib—Chills—Methotrexate—systemic lupus erythematosus	2.73e-05	0.000479	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	2.7e-05	0.000475	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	2.7e-05	0.000475	CcSEcCtD
Pazopanib—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	2.7e-05	0.000474	CcSEcCtD
Pazopanib—Myalgia—Prednisone—systemic lupus erythematosus	2.7e-05	0.000474	CcSEcCtD
Pazopanib—Arthralgia—Prednisone—systemic lupus erythematosus	2.7e-05	0.000474	CcSEcCtD
Pazopanib—Alopecia—Methotrexate—systemic lupus erythematosus	2.69e-05	0.000472	CcSEcCtD
Pazopanib—Insomnia—Dexamethasone—systemic lupus erythematosus	2.68e-05	0.000472	CcSEcCtD
Pazopanib—Insomnia—Betamethasone—systemic lupus erythematosus	2.68e-05	0.000472	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	2.68e-05	0.000471	CcSEcCtD
Pazopanib—Diarrhoea—Cyclosporine—systemic lupus erythematosus	2.67e-05	0.00047	CcSEcCtD
Pazopanib—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	2.67e-05	0.000469	CcSEcCtD
Pazopanib—Paraesthesia—Dexamethasone—systemic lupus erythematosus	2.66e-05	0.000468	CcSEcCtD
Pazopanib—Paraesthesia—Betamethasone—systemic lupus erythematosus	2.66e-05	0.000468	CcSEcCtD
Pazopanib—Mental disorder—Methotrexate—systemic lupus erythematosus	2.66e-05	0.000468	CcSEcCtD
Pazopanib—Erythema—Methotrexate—systemic lupus erythematosus	2.65e-05	0.000465	CcSEcCtD
Pazopanib—Malnutrition—Methotrexate—systemic lupus erythematosus	2.65e-05	0.000465	CcSEcCtD
Pazopanib—ABCB1—bone marrow—systemic lupus erythematosus	2.63e-05	0.000553	CbGeAlD
Pazopanib—Dyspepsia—Betamethasone—systemic lupus erythematosus	2.61e-05	0.000459	CcSEcCtD
Pazopanib—Dyspepsia—Dexamethasone—systemic lupus erythematosus	2.61e-05	0.000459	CcSEcCtD
Pazopanib—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	2.61e-05	0.000458	CcSEcCtD
Pazopanib—Dysgeusia—Methotrexate—systemic lupus erythematosus	2.59e-05	0.000455	CcSEcCtD
Pazopanib—Dizziness—Cyclosporine—systemic lupus erythematosus	2.58e-05	0.000454	CcSEcCtD
Pazopanib—Oedema—Prednisone—systemic lupus erythematosus	2.58e-05	0.000454	CcSEcCtD
Pazopanib—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	2.58e-05	0.000453	CcSEcCtD
Pazopanib—Decreased appetite—Dexamethasone—systemic lupus erythematosus	2.58e-05	0.000453	CcSEcCtD
Pazopanib—Decreased appetite—Betamethasone—systemic lupus erythematosus	2.58e-05	0.000453	CcSEcCtD
Pazopanib—Infection—Prednisone—systemic lupus erythematosus	2.57e-05	0.000451	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	2.56e-05	0.00045	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	2.56e-05	0.00045	CcSEcCtD
Pazopanib—Fatigue—Dexamethasone—systemic lupus erythematosus	2.56e-05	0.00045	CcSEcCtD
Pazopanib—Fatigue—Betamethasone—systemic lupus erythematosus	2.56e-05	0.00045	CcSEcCtD
Pazopanib—Shock—Prednisone—systemic lupus erythematosus	2.54e-05	0.000447	CcSEcCtD
Pazopanib—Pain—Dexamethasone—systemic lupus erythematosus	2.54e-05	0.000446	CcSEcCtD
Pazopanib—Pain—Betamethasone—systemic lupus erythematosus	2.54e-05	0.000446	CcSEcCtD
Pazopanib—Nervous system disorder—Prednisone—systemic lupus erythematosus	2.53e-05	0.000445	CcSEcCtD
Pazopanib—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	2.52e-05	0.000443	CcSEcCtD
Pazopanib—Skin disorder—Prednisone—systemic lupus erythematosus	2.51e-05	0.000441	CcSEcCtD
Pazopanib—Hyperhidrosis—Prednisone—systemic lupus erythematosus	2.5e-05	0.000439	CcSEcCtD
Pazopanib—Vision blurred—Methotrexate—systemic lupus erythematosus	2.49e-05	0.000438	CcSEcCtD
Pazopanib—Asthenia—Hydrocortisone—systemic lupus erythematosus	2.49e-05	0.000438	CcSEcCtD
Pazopanib—Vomiting—Cyclosporine—systemic lupus erythematosus	2.48e-05	0.000437	CcSEcCtD
Pazopanib—Rash—Cyclosporine—systemic lupus erythematosus	2.46e-05	0.000433	CcSEcCtD
Pazopanib—Anorexia—Prednisone—systemic lupus erythematosus	2.46e-05	0.000433	CcSEcCtD
Pazopanib—Dermatitis—Cyclosporine—systemic lupus erythematosus	2.46e-05	0.000433	CcSEcCtD
Pazopanib—Pruritus—Hydrocortisone—systemic lupus erythematosus	2.46e-05	0.000432	CcSEcCtD
Pazopanib—Headache—Cyclosporine—systemic lupus erythematosus	2.45e-05	0.00043	CcSEcCtD
Pazopanib—Anaemia—Methotrexate—systemic lupus erythematosus	2.45e-05	0.00043	CcSEcCtD
Pazopanib—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	2.43e-05	0.000426	CcSEcCtD
Pazopanib—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	2.43e-05	0.000426	CcSEcCtD
Pazopanib—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	2.42e-05	0.000426	CcSEcCtD
Pazopanib—Rash—Mycophenolate mofetil—systemic lupus erythematosus	2.4e-05	0.000422	CcSEcCtD
Pazopanib—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	2.4e-05	0.000422	CcSEcCtD
Pazopanib—Headache—Mycophenolate mofetil—systemic lupus erythematosus	2.39e-05	0.00042	CcSEcCtD
Pazopanib—ABCB1—lung—systemic lupus erythematosus	2.38e-05	0.000501	CbGeAlD
Pazopanib—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	2.38e-05	0.000418	CcSEcCtD
Pazopanib—Leukopenia—Methotrexate—systemic lupus erythematosus	2.37e-05	0.000416	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	2.35e-05	0.000414	CcSEcCtD
Pazopanib—Dizziness—Prednisolone—systemic lupus erythematosus	2.35e-05	0.000413	CcSEcCtD
Pazopanib—Asthenia—Triamcinolone—systemic lupus erythematosus	2.35e-05	0.000412	CcSEcCtD
Pazopanib—Abdominal pain—Dexamethasone—systemic lupus erythematosus	2.35e-05	0.000412	CcSEcCtD
Pazopanib—Abdominal pain—Betamethasone—systemic lupus erythematosus	2.35e-05	0.000412	CcSEcCtD
Pazopanib—Asthenia—Methylprednisolone—systemic lupus erythematosus	2.34e-05	0.000411	CcSEcCtD
Pazopanib—Insomnia—Prednisone—systemic lupus erythematosus	2.34e-05	0.000411	CcSEcCtD
Pazopanib—Nausea—Cyclosporine—systemic lupus erythematosus	2.32e-05	0.000408	CcSEcCtD
Pazopanib—Paraesthesia—Prednisone—systemic lupus erythematosus	2.32e-05	0.000408	CcSEcCtD
Pazopanib—Pruritus—Triamcinolone—systemic lupus erythematosus	2.31e-05	0.000407	CcSEcCtD
Pazopanib—Cough—Methotrexate—systemic lupus erythematosus	2.31e-05	0.000406	CcSEcCtD
Pazopanib—Pruritus—Methylprednisolone—systemic lupus erythematosus	2.31e-05	0.000406	CcSEcCtD
Pazopanib—Dizziness—Hydrocortisone—systemic lupus erythematosus	2.3e-05	0.000404	CcSEcCtD
Pazopanib—Dyspepsia—Prednisone—systemic lupus erythematosus	2.27e-05	0.0004	CcSEcCtD
Pazopanib—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	2.26e-05	0.000398	CcSEcCtD
Pazopanib—Myalgia—Methotrexate—systemic lupus erythematosus	2.25e-05	0.000396	CcSEcCtD
Pazopanib—Chest pain—Methotrexate—systemic lupus erythematosus	2.25e-05	0.000396	CcSEcCtD
Pazopanib—Arthralgia—Methotrexate—systemic lupus erythematosus	2.25e-05	0.000396	CcSEcCtD
Pazopanib—Decreased appetite—Prednisone—systemic lupus erythematosus	2.25e-05	0.000395	CcSEcCtD
Pazopanib—Rash—Prednisolone—systemic lupus erythematosus	2.24e-05	0.000394	CcSEcCtD
Pazopanib—Dermatitis—Prednisolone—systemic lupus erythematosus	2.24e-05	0.000394	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	2.24e-05	0.000393	CcSEcCtD
Pazopanib—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	2.23e-05	0.000392	CcSEcCtD
Pazopanib—Fatigue—Prednisone—systemic lupus erythematosus	2.23e-05	0.000392	CcSEcCtD
Pazopanib—Headache—Prednisolone—systemic lupus erythematosus	2.23e-05	0.000392	CcSEcCtD
Pazopanib—Vomiting—Hydrocortisone—systemic lupus erythematosus	2.21e-05	0.000388	CcSEcCtD
Pazopanib—ABCB1—nervous system—systemic lupus erythematosus	2.2e-05	0.000464	CbGeAlD
Pazopanib—Rash—Hydrocortisone—systemic lupus erythematosus	2.19e-05	0.000385	CcSEcCtD
Pazopanib—Dermatitis—Hydrocortisone—systemic lupus erythematosus	2.19e-05	0.000385	CcSEcCtD
Pazopanib—Headache—Hydrocortisone—systemic lupus erythematosus	2.18e-05	0.000382	CcSEcCtD
Pazopanib—Dizziness—Triamcinolone—systemic lupus erythematosus	2.16e-05	0.00038	CcSEcCtD
Pazopanib—Dizziness—Methylprednisolone—systemic lupus erythematosus	2.16e-05	0.000379	CcSEcCtD
Pazopanib—Infection—Methotrexate—systemic lupus erythematosus	2.15e-05	0.000377	CcSEcCtD
Pazopanib—Asthenia—Betamethasone—systemic lupus erythematosus	2.13e-05	0.000374	CcSEcCtD
Pazopanib—Asthenia—Dexamethasone—systemic lupus erythematosus	2.13e-05	0.000374	CcSEcCtD
Pazopanib—ABCB1—central nervous system—systemic lupus erythematosus	2.12e-05	0.000447	CbGeAlD
Pazopanib—Nervous system disorder—Methotrexate—systemic lupus erythematosus	2.12e-05	0.000372	CcSEcCtD
Pazopanib—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	2.11e-05	0.000372	CcSEcCtD
Pazopanib—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	2.11e-05	0.000371	CcSEcCtD
Pazopanib—Nausea—Prednisolone—systemic lupus erythematosus	2.11e-05	0.000371	CcSEcCtD
Pazopanib—Pruritus—Betamethasone—systemic lupus erythematosus	2.1e-05	0.000369	CcSEcCtD
Pazopanib—Pruritus—Dexamethasone—systemic lupus erythematosus	2.1e-05	0.000369	CcSEcCtD
Pazopanib—Skin disorder—Methotrexate—systemic lupus erythematosus	2.1e-05	0.000369	CcSEcCtD
Pazopanib—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	2.09e-05	0.000367	CcSEcCtD
Pazopanib—Vomiting—Triamcinolone—systemic lupus erythematosus	2.08e-05	0.000365	CcSEcCtD
Pazopanib—Vomiting—Methylprednisolone—systemic lupus erythematosus	2.07e-05	0.000365	CcSEcCtD
Pazopanib—Nausea—Hydrocortisone—systemic lupus erythematosus	2.06e-05	0.000363	CcSEcCtD
Pazopanib—Rash—Triamcinolone—systemic lupus erythematosus	2.06e-05	0.000362	CcSEcCtD
Pazopanib—Dermatitis—Triamcinolone—systemic lupus erythematosus	2.06e-05	0.000362	CcSEcCtD
Pazopanib—Anorexia—Methotrexate—systemic lupus erythematosus	2.06e-05	0.000362	CcSEcCtD
Pazopanib—Rash—Methylprednisolone—systemic lupus erythematosus	2.06e-05	0.000362	CcSEcCtD
Pazopanib—Dermatitis—Methylprednisolone—systemic lupus erythematosus	2.06e-05	0.000361	CcSEcCtD
Pazopanib—Headache—Triamcinolone—systemic lupus erythematosus	2.05e-05	0.00036	CcSEcCtD
Pazopanib—Headache—Methylprednisolone—systemic lupus erythematosus	2.04e-05	0.000359	CcSEcCtD
Pazopanib—Abdominal pain—Prednisone—systemic lupus erythematosus	2.04e-05	0.000359	CcSEcCtD
Pazopanib—Diarrhoea—Betamethasone—systemic lupus erythematosus	2.03e-05	0.000357	CcSEcCtD
Pazopanib—Diarrhoea—Dexamethasone—systemic lupus erythematosus	2.03e-05	0.000357	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	1.97e-05	0.000346	CcSEcCtD
Pazopanib—Dizziness—Betamethasone—systemic lupus erythematosus	1.96e-05	0.000345	CcSEcCtD
Pazopanib—Dizziness—Dexamethasone—systemic lupus erythematosus	1.96e-05	0.000345	CcSEcCtD
Pazopanib—Insomnia—Methotrexate—systemic lupus erythematosus	1.95e-05	0.000343	CcSEcCtD
Pazopanib—Nausea—Triamcinolone—systemic lupus erythematosus	1.94e-05	0.000341	CcSEcCtD
Pazopanib—Paraesthesia—Methotrexate—systemic lupus erythematosus	1.94e-05	0.000341	CcSEcCtD
Pazopanib—Nausea—Methylprednisolone—systemic lupus erythematosus	1.94e-05	0.000341	CcSEcCtD
Pazopanib—Dyspnoea—Methotrexate—systemic lupus erythematosus	1.93e-05	0.000338	CcSEcCtD
Pazopanib—Somnolence—Methotrexate—systemic lupus erythematosus	1.92e-05	0.000337	CcSEcCtD
Pazopanib—Dyspepsia—Methotrexate—systemic lupus erythematosus	1.9e-05	0.000334	CcSEcCtD
Pazopanib—Vomiting—Betamethasone—systemic lupus erythematosus	1.89e-05	0.000332	CcSEcCtD
Pazopanib—Vomiting—Dexamethasone—systemic lupus erythematosus	1.89e-05	0.000332	CcSEcCtD
Pazopanib—Decreased appetite—Methotrexate—systemic lupus erythematosus	1.88e-05	0.00033	CcSEcCtD
Pazopanib—Rash—Dexamethasone—systemic lupus erythematosus	1.87e-05	0.000329	CcSEcCtD
Pazopanib—Rash—Betamethasone—systemic lupus erythematosus	1.87e-05	0.000329	CcSEcCtD
Pazopanib—Dermatitis—Dexamethasone—systemic lupus erythematosus	1.87e-05	0.000329	CcSEcCtD
Pazopanib—Dermatitis—Betamethasone—systemic lupus erythematosus	1.87e-05	0.000329	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	1.86e-05	0.000328	CcSEcCtD
Pazopanib—Fatigue—Methotrexate—systemic lupus erythematosus	1.86e-05	0.000327	CcSEcCtD
Pazopanib—Headache—Betamethasone—systemic lupus erythematosus	1.86e-05	0.000327	CcSEcCtD
Pazopanib—Headache—Dexamethasone—systemic lupus erythematosus	1.86e-05	0.000327	CcSEcCtD
Pazopanib—Asthenia—Prednisone—systemic lupus erythematosus	1.85e-05	0.000326	CcSEcCtD
Pazopanib—Pain—Methotrexate—systemic lupus erythematosus	1.85e-05	0.000325	CcSEcCtD
Pazopanib—Pruritus—Prednisone—systemic lupus erythematosus	1.83e-05	0.000321	CcSEcCtD
Pazopanib—Diarrhoea—Prednisone—systemic lupus erythematosus	1.77e-05	0.000311	CcSEcCtD
Pazopanib—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	1.77e-05	0.00031	CcSEcCtD
Pazopanib—Nausea—Betamethasone—systemic lupus erythematosus	1.76e-05	0.00031	CcSEcCtD
Pazopanib—Nausea—Dexamethasone—systemic lupus erythematosus	1.76e-05	0.00031	CcSEcCtD
Pazopanib—Dizziness—Prednisone—systemic lupus erythematosus	1.71e-05	0.0003	CcSEcCtD
Pazopanib—Abdominal pain—Methotrexate—systemic lupus erythematosus	1.71e-05	0.0003	CcSEcCtD
Pazopanib—Vomiting—Prednisone—systemic lupus erythematosus	1.64e-05	0.000289	CcSEcCtD
Pazopanib—Rash—Prednisone—systemic lupus erythematosus	1.63e-05	0.000286	CcSEcCtD
Pazopanib—Dermatitis—Prednisone—systemic lupus erythematosus	1.63e-05	0.000286	CcSEcCtD
Pazopanib—Headache—Prednisone—systemic lupus erythematosus	1.62e-05	0.000285	CcSEcCtD
Pazopanib—Asthenia—Methotrexate—systemic lupus erythematosus	1.55e-05	0.000272	CcSEcCtD
Pazopanib—Nausea—Prednisone—systemic lupus erythematosus	1.54e-05	0.00027	CcSEcCtD
Pazopanib—Pruritus—Methotrexate—systemic lupus erythematosus	1.53e-05	0.000269	CcSEcCtD
Pazopanib—Diarrhoea—Methotrexate—systemic lupus erythematosus	1.48e-05	0.00026	CcSEcCtD
Pazopanib—Dizziness—Methotrexate—systemic lupus erythematosus	1.43e-05	0.000251	CcSEcCtD
Pazopanib—Vomiting—Methotrexate—systemic lupus erythematosus	1.37e-05	0.000241	CcSEcCtD
Pazopanib—Rash—Methotrexate—systemic lupus erythematosus	1.36e-05	0.000239	CcSEcCtD
Pazopanib—Dermatitis—Methotrexate—systemic lupus erythematosus	1.36e-05	0.000239	CcSEcCtD
Pazopanib—Headache—Methotrexate—systemic lupus erythematosus	1.35e-05	0.000238	CcSEcCtD
Pazopanib—Nausea—Methotrexate—systemic lupus erythematosus	1.28e-05	0.000225	CcSEcCtD
Pazopanib—FGFR2—Immune System—EP300—systemic lupus erythematosus	1.38e-06	2.08e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—C3—systemic lupus erythematosus	1.38e-06	2.07e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—F2—systemic lupus erythematosus	1.38e-06	2.07e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—F2—systemic lupus erythematosus	1.38e-06	2.06e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—CD4—systemic lupus erythematosus	1.37e-06	2.06e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—MMP9—systemic lupus erythematosus	1.37e-06	2.06e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.37e-06	2.05e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—CD80—systemic lupus erythematosus	1.36e-06	2.04e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—EP300—systemic lupus erythematosus	1.36e-06	2.04e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—CDKN1B—systemic lupus erythematosus	1.36e-06	2.03e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—CDKN1A—systemic lupus erythematosus	1.35e-06	2.03e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—CDKN1B—systemic lupus erythematosus	1.35e-06	2.03e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—CDKN1A—systemic lupus erythematosus	1.35e-06	2.03e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—CDKN1A—systemic lupus erythematosus	1.34e-06	2.01e-05	CbGpPWpGaD
Pazopanib—FGF1—Disease—TGFB1—systemic lupus erythematosus	1.34e-06	2.01e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.33e-06	2e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.32e-06	1.99e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CD80—systemic lupus erythematosus	1.32e-06	1.98e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CDKN1B—systemic lupus erythematosus	1.32e-06	1.98e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CCL2—systemic lupus erythematosus	1.32e-06	1.98e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CD80—systemic lupus erythematosus	1.32e-06	1.98e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—CDKN1A—systemic lupus erythematosus	1.32e-06	1.98e-05	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—IL6—systemic lupus erythematosus	1.32e-06	1.98e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—IL6—systemic lupus erythematosus	1.3e-06	1.95e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—EP300—systemic lupus erythematosus	1.3e-06	1.95e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—NAT2—systemic lupus erythematosus	1.3e-06	1.95e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—CD4—systemic lupus erythematosus	1.3e-06	1.94e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CCL2—systemic lupus erythematosus	1.3e-06	1.94e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—IL2—systemic lupus erythematosus	1.29e-06	1.94e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—CDKN1B—systemic lupus erythematosus	1.29e-06	1.94e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL2—systemic lupus erythematosus	1.29e-06	1.94e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.29e-06	1.94e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—EP300—systemic lupus erythematosus	1.29e-06	1.93e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—PTGS2—systemic lupus erythematosus	1.29e-06	1.93e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—EP300—systemic lupus erythematosus	1.29e-06	1.93e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—EP300—systemic lupus erythematosus	1.28e-06	1.92e-05	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—IL6—systemic lupus erythematosus	1.28e-06	1.91e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL2—systemic lupus erythematosus	1.26e-06	1.9e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—IL2—systemic lupus erythematosus	1.26e-06	1.89e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—PPARG—systemic lupus erythematosus	1.25e-06	1.88e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—EP300—systemic lupus erythematosus	1.25e-06	1.88e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—CDKN1A—systemic lupus erythematosus	1.25e-06	1.88e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—CDKN1A—systemic lupus erythematosus	1.25e-06	1.87e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—TYK2—systemic lupus erythematosus	1.24e-06	1.87e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—F2—systemic lupus erythematosus	1.24e-06	1.86e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.23e-06	1.85e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.23e-06	1.85e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CCL2—systemic lupus erythematosus	1.23e-06	1.84e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CCL2—systemic lupus erythematosus	1.23e-06	1.84e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—MMP9—systemic lupus erythematosus	1.23e-06	1.84e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—JAK1—systemic lupus erythematosus	1.22e-06	1.84e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.22e-06	1.83e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—CDKN1B—systemic lupus erythematosus	1.22e-06	1.83e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CDKN1A—systemic lupus erythematosus	1.22e-06	1.83e-05	CbGpPWpGaD
Pazopanib—FGFR3—Disease—IL6—systemic lupus erythematosus	1.22e-06	1.82e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—F2—systemic lupus erythematosus	1.21e-06	1.82e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—IL2—systemic lupus erythematosus	1.2e-06	1.81e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TYK2—systemic lupus erythematosus	1.2e-06	1.8e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—MMP9—systemic lupus erythematosus	1.19e-06	1.79e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—CDKN1A—systemic lupus erythematosus	1.19e-06	1.79e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.19e-06	1.79e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—EP300—systemic lupus erythematosus	1.19e-06	1.79e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CD80—systemic lupus erythematosus	1.19e-06	1.78e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—EP300—systemic lupus erythematosus	1.19e-06	1.78e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TYK2—systemic lupus erythematosus	1.18e-06	1.76e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—NOS3—systemic lupus erythematosus	1.18e-06	1.76e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.17e-06	1.75e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IFNG—systemic lupus erythematosus	1.17e-06	1.75e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CD80—systemic lupus erythematosus	1.16e-06	1.75e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—EP300—systemic lupus erythematosus	1.16e-06	1.74e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CCR5—systemic lupus erythematosus	1.16e-06	1.74e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—EP300—systemic lupus erythematosus	1.16e-06	1.74e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—NOS3—systemic lupus erythematosus	1.15e-06	1.73e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—TYK2—systemic lupus erythematosus	1.15e-06	1.72e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PPARG—systemic lupus erythematosus	1.15e-06	1.72e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.14e-06	1.71e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.14e-06	1.71e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.14e-06	1.7e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—EP300—systemic lupus erythematosus	1.13e-06	1.7e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—C3—systemic lupus erythematosus	1.13e-06	1.7e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—EP300—systemic lupus erythematosus	1.13e-06	1.7e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.13e-06	1.7e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—NOS3—systemic lupus erythematosus	1.13e-06	1.69e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—ALB—systemic lupus erythematosus	1.13e-06	1.69e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—CD4—systemic lupus erythematosus	1.13e-06	1.69e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—CDKN1A—systemic lupus erythematosus	1.12e-06	1.69e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TYK2—systemic lupus erythematosus	1.12e-06	1.67e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—IL6—systemic lupus erythematosus	1.11e-06	1.67e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TYK2—systemic lupus erythematosus	1.11e-06	1.67e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—TGFB1—systemic lupus erythematosus	1.11e-06	1.67e-05	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.1e-06	1.66e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CCL2—systemic lupus erythematosus	1.1e-06	1.66e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.1e-06	1.65e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—NOS3—systemic lupus erythematosus	1.1e-06	1.64e-05	CbGpPWpGaD
Pazopanib—FGF1—Immune System—IL6—systemic lupus erythematosus	1.09e-06	1.64e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—NOS3—systemic lupus erythematosus	1.09e-06	1.64e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—TGFB1—systemic lupus erythematosus	1.09e-06	1.64e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CCL2—systemic lupus erythematosus	1.08e-06	1.62e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—EP300—systemic lupus erythematosus	1.08e-06	1.62e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—NOS3—systemic lupus erythematosus	1.08e-06	1.62e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.07e-06	1.61e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—EP300—systemic lupus erythematosus	1.07e-06	1.6e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PPARG—systemic lupus erythematosus	1.06e-06	1.6e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—CDKN1B—systemic lupus erythematosus	1.06e-06	1.59e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—RXRA—systemic lupus erythematosus	1.05e-06	1.57e-05	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—IL6—systemic lupus erythematosus	1.05e-06	1.57e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—CD4—systemic lupus erythematosus	1.04e-06	1.56e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL2—systemic lupus erythematosus	1.04e-06	1.55e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—TGFB1—systemic lupus erythematosus	1.03e-06	1.55e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—ALB—systemic lupus erythematosus	1.03e-06	1.55e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—TGFB1—systemic lupus erythematosus	1.03e-06	1.55e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—PTGS2—systemic lupus erythematosus	1.03e-06	1.55e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.03e-06	1.55e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.02e-06	1.54e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.02e-06	1.53e-05	CbGpPWpGaD
Pazopanib—FGF1—Disease—IL6—systemic lupus erythematosus	1.01e-06	1.52e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.01e-06	1.52e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TYK2—systemic lupus erythematosus	1e-06	1.51e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	1e-06	1.5e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1e-06	1.5e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—IL2—systemic lupus erythematosus	9.96e-07	1.5e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—F2—systemic lupus erythematosus	9.94e-07	1.49e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—NOS3—systemic lupus erythematosus	9.88e-07	1.48e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—PTGS2—systemic lupus erythematosus	9.87e-07	1.48e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—TGFB1—systemic lupus erythematosus	9.84e-07	1.48e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—NOS3—systemic lupus erythematosus	9.84e-07	1.48e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TYK2—systemic lupus erythematosus	9.82e-07	1.47e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—IL2—systemic lupus erythematosus	9.79e-07	1.47e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—CDKN1B—systemic lupus erythematosus	9.77e-07	1.47e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—CDKN1A—systemic lupus erythematosus	9.77e-07	1.47e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	9.7e-07	1.46e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—NOS3—systemic lupus erythematosus	9.64e-07	1.45e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—ALB—systemic lupus erythematosus	9.57e-07	1.44e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CD80—systemic lupus erythematosus	9.53e-07	1.43e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	9.49e-07	1.42e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CDKN1B—systemic lupus erythematosus	9.47e-07	1.42e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—MMP9—systemic lupus erythematosus	9.43e-07	1.42e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	9.4e-07	1.41e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TGFB1—systemic lupus erythematosus	9.39e-07	1.41e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—TGFB1—systemic lupus erythematosus	9.3e-07	1.4e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—EP300—systemic lupus erythematosus	9.29e-07	1.39e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IL2—systemic lupus erythematosus	9.29e-07	1.39e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	9.27e-07	1.39e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IL2—systemic lupus erythematosus	9.26e-07	1.39e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—MMP9—systemic lupus erythematosus	9.26e-07	1.39e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CDKN1A—systemic lupus erythematosus	9.23e-07	1.38e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—NOS3—systemic lupus erythematosus	9.15e-07	1.37e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	9.11e-07	1.37e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—IL6—systemic lupus erythematosus	9.06e-07	1.36e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PTGS2—systemic lupus erythematosus	9.04e-07	1.36e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—CDKN1A—systemic lupus erythematosus	9.02e-07	1.35e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—EP300—systemic lupus erythematosus	8.94e-07	1.34e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—IL6—systemic lupus erythematosus	8.9e-07	1.34e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CCL2—systemic lupus erythematosus	8.86e-07	1.33e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—MMP9—systemic lupus erythematosus	8.79e-07	1.32e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—EP300—systemic lupus erythematosus	8.78e-07	1.32e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—MMP9—systemic lupus erythematosus	8.77e-07	1.32e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	8.76e-07	1.31e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CDKN1A—systemic lupus erythematosus	8.74e-07	1.31e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	8.59e-07	1.29e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—EP300—systemic lupus erythematosus	8.58e-07	1.29e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CDKN1B—systemic lupus erythematosus	8.53e-07	1.28e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—IL6—systemic lupus erythematosus	8.51e-07	1.28e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—VEGFA—systemic lupus erythematosus	8.47e-07	1.27e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IL6—systemic lupus erythematosus	8.44e-07	1.27e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IL6—systemic lupus erythematosus	8.42e-07	1.26e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PTGS2—systemic lupus erythematosus	8.37e-07	1.26e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—IL6—systemic lupus erythematosus	8.36e-07	1.26e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CDKN1B—systemic lupus erythematosus	8.35e-07	1.25e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL2—systemic lupus erythematosus	8.34e-07	1.25e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—EP300—systemic lupus erythematosus	8.33e-07	1.25e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—VEGFA—systemic lupus erythematosus	8.32e-07	1.25e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—EP300—systemic lupus erythematosus	8.31e-07	1.25e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—IL6—systemic lupus erythematosus	8.21e-07	1.23e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—EP300—systemic lupus erythematosus	8.2e-07	1.23e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL2—systemic lupus erythematosus	8.17e-07	1.23e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	8.11e-07	1.22e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TYK2—systemic lupus erythematosus	8.05e-07	1.21e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—NOS3—systemic lupus erythematosus	7.9e-07	1.19e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MMP9—systemic lupus erythematosus	7.9e-07	1.19e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—VEGFA—systemic lupus erythematosus	7.89e-07	1.18e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—VEGFA—systemic lupus erythematosus	7.87e-07	1.18e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CDKN1A—systemic lupus erythematosus	7.87e-07	1.18e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—IL6—systemic lupus erythematosus	7.79e-07	1.17e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—IL6—systemic lupus erythematosus	7.77e-07	1.17e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TGFB1—systemic lupus erythematosus	7.77e-07	1.17e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MMP9—systemic lupus erythematosus	7.73e-07	1.16e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CDKN1A—systemic lupus erythematosus	7.7e-07	1.16e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TGFB1—systemic lupus erythematosus	7.63e-07	1.15e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—IL6—systemic lupus erythematosus	7.61e-07	1.14e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL6—systemic lupus erythematosus	7.59e-07	1.14e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—EP300—systemic lupus erythematosus	7.52e-07	1.13e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—EP300—systemic lupus erythematosus	7.49e-07	1.12e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—TGFB1—systemic lupus erythematosus	7.46e-07	1.12e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL6—systemic lupus erythematosus	7.43e-07	1.11e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—IL6—systemic lupus erythematosus	7.42e-07	1.11e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—EP300—systemic lupus erythematosus	7.33e-07	1.1e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	7.27e-07	1.09e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TGFB1—systemic lupus erythematosus	7.24e-07	1.09e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TGFB1—systemic lupus erythematosus	7.23e-07	1.08e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—VEGFA—systemic lupus erythematosus	7.09e-07	1.06e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—IL6—systemic lupus erythematosus	7.08e-07	1.06e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—IL6—systemic lupus erythematosus	7e-07	1.05e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—EP300—systemic lupus erythematosus	6.96e-07	1.04e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—VEGFA—systemic lupus erythematosus	6.94e-07	1.04e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.84e-07	1.03e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	6.75e-07	1.01e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL2—systemic lupus erythematosus	6.7e-07	1.01e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PPARG—systemic lupus erythematosus	6.6e-07	9.91e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TGFB1—systemic lupus erythematosus	6.51e-07	9.77e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TGFB1—systemic lupus erythematosus	6.37e-07	9.56e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MMP9—systemic lupus erythematosus	6.34e-07	9.51e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CDKN1A—systemic lupus erythematosus	6.32e-07	9.48e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL6—systemic lupus erythematosus	6.09e-07	9.14e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—EP300—systemic lupus erythematosus	6.01e-07	9.02e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ALB—systemic lupus erythematosus	5.94e-07	8.91e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—IL6—systemic lupus erythematosus	5.86e-07	8.79e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	5.75e-07	8.63e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—IL6—systemic lupus erythematosus	5.75e-07	8.63e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.69e-07	8.54e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—NOS3—systemic lupus erythematosus	5.68e-07	8.52e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—IL6—systemic lupus erythematosus	5.62e-07	8.44e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	5.61e-07	8.43e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IL6—systemic lupus erythematosus	5.46e-07	8.19e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IL6—systemic lupus erythematosus	5.44e-07	8.17e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	5.42e-07	8.14e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.22e-07	7.84e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PTGS2—systemic lupus erythematosus	5.19e-07	7.8e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ALB—systemic lupus erythematosus	5.17e-07	7.76e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	4.95e-07	7.43e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL6—systemic lupus erythematosus	4.9e-07	7.36e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	4.87e-07	7.32e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL6—systemic lupus erythematosus	4.8e-07	7.21e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	4.66e-07	7e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	4.59e-07	6.89e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	4.53e-07	6.79e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—EP300—systemic lupus erythematosus	4.32e-07	6.48e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	4.26e-07	6.4e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	4.13e-07	6.2e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	3.95e-07	5.93e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL6—systemic lupus erythematosus	3.94e-07	5.91e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—EP300—systemic lupus erythematosus	3.76e-07	5.65e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	3.61e-07	5.42e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	3.55e-07	5.32e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	3.54e-07	5.32e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	3.19e-07	4.78e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	3.05e-07	4.58e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	3e-07	4.51e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	2.79e-07	4.18e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	2.32e-07	3.48e-06	CbGpPWpGaD
